191 related articles for article (PubMed ID: 26162922)
1. Correlation of Radiologic with Surgical Peritoneal Cancer Index Scores in Patients with Pseudomyxoma Peritonei and Peritoneal Carcinomatosis: How Well Can We Predict Resectability?
Flicek K; Ashfaq A; Johnson CD; Menias C; Bagaria S; Wasif N
J Gastrointest Surg; 2016 Feb; 20(2):307-12. PubMed ID: 26162922
[TBL] [Abstract][Full Text] [Related]
2. Optimal peritoneal cancer index cutoff point for predicting surgical resectability of pseudomyxoma peritonei in treatment-naive patients.
Bai M; Li Y; Pu H; Xu Y; Chen J; Xu H; Wei H; Liang G; Ma R; Feng J
World J Surg Oncol; 2024 Jan; 22(1):39. PubMed ID: 38297355
[TBL] [Abstract][Full Text] [Related]
3. Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis from pseudomyxoma peritonei.
Cioppa T; Vaira M; Bing C; D'Amico S; Bruscino A; De Simone M
World J Gastroenterol; 2008 Nov; 14(44):6817-23. PubMed ID: 19058307
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Resectability in Pseudomyxoma Peritonei with a New CT Score.
Bouquot M; Dohan A; Gayat E; Barat M; Glehen O; Pocard M; Rousset P; Eveno C
Ann Surg Oncol; 2018 Mar; 25(3):694-701. PubMed ID: 29192372
[TBL] [Abstract][Full Text] [Related]
5. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Langer M; Andreola S; Favaro M; Gavazzi C; Laterza B; Deraco M
Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
[TBL] [Abstract][Full Text] [Related]
6. Combined ultrasonography and CT for prognosis and predicting clinical outcomes of patients with pseudomyxoma peritonei.
Han X; Zhang Q; Zhou N; Ma R; Wang J; Zhai X; Cui B; Lu Y; Liang L
Eur Radiol; 2023 Apr; 33(4):2800-2808. PubMed ID: 36418618
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of radiologic- laparoscopic peritoneal carcinomatosis categorization in the prediction of surgical outcome.
Abdalla Ahmed S; Abou-Taleb H; Ali N; M Badary D
Br J Radiol; 2019 Aug; 92(1100):20190163. PubMed ID: 31112412
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of positron emission tomography in the staging of pseudomyxoma peritonei.
Flood MP; Kong JC; Pham T; Waters PS; Soucisse M; Ramsay R; Wong HL; Mitchell C; Michael M; McCormick JJ; Warrier SK; Akhurst T; Heriot AG
Eur J Surg Oncol; 2022 Jul; 48(7):1606-1613. PubMed ID: 35148916
[TBL] [Abstract][Full Text] [Related]
9. Value of preoperative ultrasound in evaluating the peritoneal cancer index of pseudomyxoma peritonei.
Liang L; Wang W; Zhou N; Guo J; Lu Y; Xu H; Zhang S
World J Surg Oncol; 2019 Nov; 17(1):192. PubMed ID: 31718654
[TBL] [Abstract][Full Text] [Related]
10. Two-step cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei with high peritoneal carcinomatosis index.
Trilling B; Brind'Amour A; Hamad R; Tremblay JF; Dubé P; Mitchell A; Sidéris L
World J Surg Oncol; 2021 Feb; 19(1):60. PubMed ID: 33622339
[TBL] [Abstract][Full Text] [Related]
11. Treatment of peritoneal carcinomatosis from colonic cancer by cytoreduction, peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC). Experience of ten years.
Vaira M; Cioppa T; D'Amico S; de Marco G; D'Alessandro M; Fiorentini G; De Simone M
In Vivo; 2010; 24(1):79-84. PubMed ID: 20133981
[TBL] [Abstract][Full Text] [Related]
12. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
14. Pseudomyxoma peritonei (PMP) and its therapy - 20 years experience of a single surgical department.
Bartoška P; Antoš F; Vítek P; Marx J; Holečková P; Novotný M; Kengbaeva M
Rozhl Chir; 2020; 99(4):159-166. PubMed ID: 32545978
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of complete cytoreductive surgery and two intraperitoneal chemotherapy techniques in Pseudomyxoma peritonei.
Sørensen O; Flatmark K; Reed W; Wiig JN; Dueland S; Giercksky KE; Larsen SG
Eur J Surg Oncol; 2012 Oct; 38(10):969-76. PubMed ID: 22763244
[TBL] [Abstract][Full Text] [Related]
16. FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei.
Dubreuil J; Giammarile F; Rousset P; Bakrin N; Passot G; Isaac S; Glehen O; Skanjeti A
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1630-7. PubMed ID: 26907364
[TBL] [Abstract][Full Text] [Related]
17. Pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic chemotherapy: a 7-year single-center experience.
Virzì S; Iusco D; Bonomi S; Grassi A
Tumori; 2012; 98(5):588-93. PubMed ID: 23235753
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei].
Lei ZY; Ding BH; Wu QY; Luo JL; Li Z; Wang T; Wang YS; Chen YX; Huang LF; He JF; Yang XS; Guan TP; Ruan Q; Wang JH; Tang HS; Wang J; Cui SZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Dec; 26(12):1179-1186. PubMed ID: 38110280
[No Abstract] [Full Text] [Related]
19. Bland-Altman agreement analysis between CT predicted and surgical peritoneal cancer index in pseudomyxoma peritonei of appendiceal origin.
Bai M; Chen J; Xu Y; Feng J; Ma R; Jia H; Xu H; Liang G; Wei H
Sci Rep; 2023 Dec; 13(1):21520. PubMed ID: 38057378
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cytoreductive surgery and HIPEC for peritoneal surface malignancies: analysis of 384 consecutive cases.
Narasimhan V; Das A; Warrier S; Lynch C; McCormick J; Tie J; Michael M; Ramsay R; Heriot A
Langenbecks Arch Surg; 2019 Aug; 404(5):527-539. PubMed ID: 31377856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
